AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 24445356
Drug: Vitamin K1
RxNorm normalized name: vitamin K1
DrugBank: Phylloquinone (DB01022)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin K1 injection in the Spleen‐6 (SP‐6) acupuncture point
Trial: 24445356
Drug: Saline injection
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Saline injection in a nonacupuncture point
Trial: 24445356
Drug: Vitamin K1
RxNorm normalized name: vitamin K1
DrugBank: Phylloquinone (DB01022)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin K1 injection
Trial: 8367870
Drug: Combined perioperative
RxNorm normalized name: ENSURE SURGERY PERIOPERATIVE KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined perioperative infusion of nifedipine (10 micrograms/kg/h) and metoprolol (12 micrograms/kg/h)
Trial: 2558882
Drug: Meals with
RxNorm normalized name: bone meal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Meals with added table salt (4.25 g)
Trial: 27467589
Drug: Valencia model
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valencia model of waking hypnosis plus cognitive‐behavioral therapy (VMWH‐CBT)
Trial: 16915107
Drug: Albumin administration
RxNorm normalized name: Albumin Aggregated
DrugBank: Albumin Aggregated (DB14230)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albumin administration (300 mL of 20% albumin solution on the first day, then 200 mL/day if serum albumin <31 g/dL)
Trial: 12419083
Drug: Intranasal estradiol
RxNorm normalized name: Estradiol
DrugBank: Estradiol acetate (DB13952)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intranasal estradiol 150 microg/day
Trial: 12419083
Drug: Intranasal estradiol
RxNorm normalized name: Estradiol
DrugBank: Estradiol acetate (DB13952)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intranasal estradiol 300 microg/day
Trial: 10599387
Drug: Tretinoin cream
RxNorm normalized name: Tretinoin Cream
DrugBank: Tretinoin (DB00755)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tretinoin cream 0.1% applied every evening and hydroquinone lotion 3% applied every morning
Trial: 1777832
Drug: Budesonide, 200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Budesonide, 200 micrograms once daily in each nostril
Trial: 31240995
Drug: BUD/FORM plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BUD/FORM plus I+T (160/4.5 µg; two inhalations twice daily via Turbuhaler®) + I (20 µg per inhalation, two inhalations four times daily) + T (100 mg bid)
Trial: 26281342
Drug: Wound infiltration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Wound infiltration with 4 mg of lornoxicam
Trial: 22032053
Drug: Early atropine-dobutamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Early atropine-dobutamine stress echocardiography (EA-DSE); atropine started at dobutamine infusion rate of 20 microg/kg/min, max dose 2.0 mg.
Trial: 18765698
Drug: Episodic antiretroviral
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Episodic antiretroviral therapy
Trial: 17971716
Drug: Continuous antiretroviral
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous antiretroviral therapy
Trial: 18617640
Drug: Current smokers
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Current smokers on continuous HIV treatment
Trial: 26987315
Drug: Unified protocol
RxNorm normalized name: RAYON,PURIFIED
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Unified protocol combined with treatment-as-usual
Trial: 26987315
Drug: Waiting-list with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Waiting-list with treatment-as-usual
Trial: 25609654
Drug: Probiotics (10^9
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Probiotics (10^9 cfu Bifobacterium bifidum A218, 10^9 cfu Bifobacterium catenulatum A302, 10^9 cfu Bifobacterium longum A101, 10^9 cfu Lactobacillus plantarum A87 daily for six months)
Trial: 25609654
Drug: Placebo (maltodextrin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (maltodextrin capsules for six months)
Trial: 23532298
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (HbA1c-based treatment, n = 65)
Trial: 18991077
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg oral micronized estradiol therapy
Trial: 18991077
Drug: 2 mg
RxNorm normalized name: iodine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg oral micronized estradiol therapy
Trial: 16842669
Drug: IL‐6/‐572C/G genotype
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IL‐6/‐572C/G genotype
Trial: 16842669
Drug: IL‐6/‐572 C/G
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IL‐6/‐572 C/G polymorphism
Trial: 9089901
Drug: Omega-3 fatty
RxNorm normalized name: Omega-3 fatty acid
DrugBank: Omega-3 fatty acids (DB11133)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omega-3 fatty acid supplementation (5.2 g of concentrated fish oil triglyceride, 1.60 g/day EPA and 1.04 g/day DHA)
Trial: 9089901
Drug: Placebo (5.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (5.2 g corn oil)
Trial: 26489511
Drug: Danhong injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Danhong injection
Trial: 31160171
Drug: Ribociclib 600
RxNorm normalized name: letrozole 2.5 MG / ribociclib 600 MG Daily Dose Carton
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ribociclib 600 mg/d (3 weeks on/1 week off) with letrozole 2.5 mg/d (continuous)
Trial: 26632082
Drug: Single oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single oral dose of guaifenesin (age‐based doses of 100‐400 mg)
Trial: 20013603
Drug: Gum chewing
RxNorm normalized name: Nicotine (as nicotine polacrilex) 4 mg oral gum chewing gum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gum chewing (group G, N = 193)
Trial: 18667293
Drug: Behavior therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Behavior therapy for 12 weeks
Trial: 16248238
Drug: Compound Danshen
RxNorm normalized name: DANSHEN
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Compound Danshen Droplet‐pill (DS) combined with trimetazidine (TMZ)
Trial: 8277091
Drug: Sulodexide (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sulodexide (600 LRU intramuscular injection for 1 month, followed by 500 LRU oral capsules twice daily)
Trial: 1187285
Drug: 8 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8 mg/kg oral dose of a new xanthone drug
Trial: 16613260
Drug: Fluoxetine plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoxetine plus Sanpu Xinnao Xin granule (Group B)
Trial: 16613260
Drug: Fluoxetine plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoxetine plus Xiaoyao pill (Group C)
Trial: 10655394
Drug: FluMist vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FluMist vaccine (cold-adapted H1N1, H3N2, and B influenza viruses)
Trial: 1564689
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of rinsing with 0.2 percent neutral NaF solution and chewing 2.2 mg NaF tablet
Trial: 1564689
Drug: Fluoride tablets
RxNorm normalized name: Sodium Fluoride Tablets
DrugBank: Sodium fluorophosphate (DB09484)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoride tablets (2.2 mg NaF tablet)
Trial: 1564689
Drug: Fluoride rinse
RxNorm normalized name: ACT Fluoride Rinse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoride rinse (0.2 percent neutral NaF solution)
Trial: 4076202
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy (Nicardipine + Metoprolol)
Trial: 4076202
Drug: Nicardipine (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicardipine (10 mg) during dynamic exercise
Trial: 4076202
Drug: Metoprolol (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol (10 mg) during dynamic exercise
Trial: 4076202
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy (Nicardipine + Metoprolol) during dynamic exercise
Trial: 26683007
Drug: 0.5 ml
RxNorm normalized name: ethanol 0.5 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 ml of HA/Col
Trial: 25060156
Drug: Capsaicin and
RxNorm normalized name: Capsaicin and similar agents
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Capsaicin and dihydrocapsaicin combination in 30c potency
Trial: 22564839
Drug: 800 mg
RxNorm normalized name: bran 800 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 800 mg ofloxacin daily
Trial: 22564839
Drug: 1,600 mg
RxNorm normalized name: omega-3/dha/epa/fish oil 1,600 mg-500 mg-800 mg/5 mL ORAL LIQUID (ML)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1,600 mg ofloxacin daily
Trial: 20575288
Drug: Electroacupuncture combined
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Electroacupuncture combined with acupoint-injection of botulinum toxin A (Group A)
Trial: 20575288
Drug: Acupoint-injection of
RxNorm normalized name: purified protein derivative of tuberculin Injectable Solution [Aplisol]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupoint-injection of botulinum toxin A (Group B)
Trial: 10502572
Drug: Suction applied
RxNorm normalized name: cetylpyridinium
DrugBank: Cetylpyridinium (DB11073)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Suction applied under ophthalmic drapes
Trial: 10502572
Drug: No suction
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No suction used under ophthalmic drapes
Trial: 24992553
Drug: Cetirizine 10
RxNorm normalized name: cetirizine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cetirizine 10 mg daily
Trial: 27240198
Drug: Iodine group
RxNorm normalized name: Iodine
DrugBank: Iodine (DB05382)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Iodine group (30 patients); aqueous iodine solution applied intrapleurally.
Trial: 27240198
Drug: Doxycycline group
RxNorm normalized name: Doxycycline
DrugBank: Doxycycline (DB00254)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Doxycycline group (34 patients); 200 mg of Doxycycline given.
Trial: 27240198
Drug: Drainage group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drainage group (35 patients); Lidocaine solution only applied.
Trial: 8831399
Drug: 30 mg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg/day vesnarinone
Trial: 8831399
Drug: 60 mg/day
RxNorm normalized name: cabozantinib s-malate 60 mg/day (20 mg x 3/day) ORAL CAPSULE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 mg/day vesnarinone
Trial: 25579777
Drug: 23-valent polysaccharide
RxNorm normalized name: pneumococcal 23-valent polysaccharide vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 23-valent polysaccharide pneumococcal vaccine (PPV23)
Trial: 20117269
Drug: 3 doses
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 3 doses of 7-valent pneumococcal conjugate vaccine (PCV7)
Trial: 15578203
Drug: Caffeine (6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caffeine (6 mg kg(‐1) body mass)
Trial: 12168365
Drug: Conventional treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional treatment (without hypothermia)
Trial: 10534584
Drug: Maprotiline (up
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maprotiline (up to 150 mg daily)
Trial: 10534584
Drug: Paroxetine (up
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paroxetine (up to 30 mg daily)
Trial: 10534584
Drug: Active placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active placebo (diphenhydramine hydrochloride up to 37.5 mg daily)
Trial: 30737046
Drug: Long-term weekly
RxNorm normalized name: benzethonium
DrugBank: Benzethonium (DB11125)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Long-term weekly iron supplementation
Trial: 25549765
Drug: LPS (0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LPS (0.3 ng/kg body weight) injection in trained (T) group
Trial: 25549765
Drug: LPS (0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LPS (0.3 ng/kg body weight) injection in untrained (UT) group
Trial: 15377055
Drug: Nutritional supplements
RxNorm normalized name: nutritional supplements
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nutritional supplements and psychological therapy
Trial: 9553912
Drug: Dithranol ointment
RxNorm normalized name: Zithranol
DrugBank: Anthralin (DB11157)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dithranol ointment treatment
Trial: 3323113
Drug: iohexol 350
RxNorm normalized name: iohexol 350 mg/mL injectable solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: iohexol 350 mg I/mL
Trial: 3323113
Drug: ioxaglate 320
RxNorm normalized name: ioxaglate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ioxaglate 320 mg I/mL
Trial: 28872898
Drug: Coping Skills
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Coping Skills Training (CST) program - six weekly telephone sessions plus access to a study website
Trial: 22420841
Drug: Azithromycin (one
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azithromycin (one drop twice daily for 3 days)
Trial: 22420841
Drug: Tobramycin (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tobramycin (1 drop 4 times daily until complete re-epithelialization)
Trial: 23994420
Drug: Allopurinol 600
RxNorm normalized name: Allopurinol
DrugBank: Allopurinol (DB00437)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Allopurinol 600 mg/day
Trial: 18681754
Drug: Dipyridamole 200
RxNorm normalized name: dipyridamole 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dipyridamole 200 mg/day
Trial: 6813481
Drug: Auranofin (AF)
RxNorm normalized name: Auranofin
DrugBank: Auranofin (DB00995)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Auranofin (AF) 3 mg bid
Trial: 26584195
Drug: Anakinra (recombinant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anakinra (recombinant interleukin‐1 receptor antagonist)
Trial: 15195012
Drug: 100 ml
RxNorm normalized name: PVC IV Bag 100 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 ml of contrast material at 4 ml/s followed by 40 ml of saline chaser at 4 ml/s
Trial: 15195012
Drug: 140 ml
RxNorm normalized name: syringe, disposable, 140 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 140 ml of contrast material at 4 ml/s
Trial: 11402632
Drug: tolterodine 2
RxNorm normalized name: tolterodine 2 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: tolterodine 2 mg bid (total 4 mg/d)
Trial: 11402632
Drug: trospium chloride
RxNorm normalized name: Trospium Chloride
DrugBank: Trospium (DB00209)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: trospium chloride 15 mg tid (total 45 mg/d)
Trial: 11402632
Drug: oxybutynin 5
RxNorm normalized name: oxyBUTYnin 5 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: oxybutynin 5 mg tid (total 15 mg/d)
Trial: 9737760
Drug: Acetazolamide (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetazolamide (500 mg sustained-release capsule once daily) plus low-dose dexamethasone (4 mg every 12 h)
Trial: 9737760
Drug: Acetazolamide (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetazolamide (500 mg once daily) plus placebo (every 12 h)
Trial: 7977146
Drug: Milk chocolate
RxNorm normalized name: Meritene Milk Chocolate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Milk chocolate bar (46 g)
Trial: 2593864
Drug: Norethisterone acetate
RxNorm normalized name: Norethisterone acetate
DrugBank: Norethisterone (DB00717)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Norethisterone acetate 1 mg (Group A)
Trial: 2593864
Drug: Norethisterone acetate
RxNorm normalized name: Norethisterone acetate
DrugBank: Norethisterone (DB00717)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Norethisterone acetate 0.5 mg (Group B)
Trial: 2593864
Drug: Megestrol acetate
RxNorm normalized name: Megestrol Acetate
DrugBank: Megestrol (DB19378)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Megestrol acetate 5 mg (Group C)
Trial: 2593864
Drug: Megestrol acetate
RxNorm normalized name: Megestrol Acetate
DrugBank: Megestrol (DB19378)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Megestrol acetate 2.5 mg (Group D)
Trial: 2593864
Drug: High progestogen
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High progestogen doses (Norethisterone acetate 1 mg and Megestrol acetate 5 mg)
Trial: 2593864
Drug: High progestogen
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High progestogen doses (Norethisterone acetate 1 mg and Megestrol acetate 5 mg) with women under 67 kg or last menstruation over 5 years ago
Trial: 30192327
Drug: Intravenous furosemide
RxNorm normalized name: Furosemide
DrugBank: Furosemide (DB00695)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous furosemide plus enhanced recovery after surgery on postoperative day 1 and 2
Trial: 15881949
Drug: Pneumo 23
DrugBank: Streptococcus pneumoniae type 33F capsular polysaccharide diphtheria CRM197 protein conjugate antigen (DB16711)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pneumo 23 vaccine
Trial: 19025058
Drug: Aniracetam (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aniracetam (400 mg, 2 x 200 mg/capsule)
Trial: 19025058
Drug: Reference formulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reference formulation of Aniracetam (400 mg)
Trial: 11473680
Drug: Montelukast (active
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Montelukast (active treatment)
Trial: 10028858
Drug: Oral prednisone
RxNorm normalized name: Prednisone
DrugBank: Prednisone acetate (DB14646)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral prednisone (2.2 mg/kg/day for 3 weeks, tapered within 1 week) followed by rIFN-alpha (same dose as above)
Trial: 8015423
Drug: Naftidrofuryl (vasoactive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naftidrofuryl (vasoactive drug) administered postoperatively
Trial: 2778114
Drug: Topically applied
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Topically applied corticosteroid formulations of different potencies
Trial: 31573086
Drug: Standard treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard treatment (no EIPL)
Trial: 28279542
Drug: Ketamine 0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketamine 0.3 mg/kg via intravenous piggyback over 15 min
Trial: 25080450
Drug: Daclatasvir 20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daclatasvir 20 mg
Trial: 24451151
Drug: Daclatasvir 60
RxNorm normalized name: daclatasvir 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daclatasvir 60 mg
Trial: 25080450
Drug: Daclatasvir 20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daclatasvir 20 mg (Genotype 4)
Trial: 25080450
Drug: Daclatasvir 60
RxNorm normalized name: daclatasvir 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daclatasvir 60 mg (Genotype 4)
Trial: 19826270
Drug: Fluid resuscitation
RxNorm normalized name: amniotic fluid (bovine)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluid resuscitation guided by hourly urine output
Trial: 16477215
Drug: Lipid formulation
RxNorm normalized name: guggul lipids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lipid formulation of AmB (Control)
Trial: 10796750
Drug: Other drugs
RxNorm normalized name: Other drugs for bile therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Other drugs (Gabapentine, Clonidine, Diazepam, Amytal, oral Baclofen)
Trial: 2873015
Drug: Drug-treated group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug-treated group (hydrochlorothiazide, propranolol, methyldopa)
Trial: 2873015
Drug: Drug-treated group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug-treated group
Trial: 29626416
Drug: Continuous administration
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous administration of 16 mU/min (Group I)
Trial: 29626416
Drug: 5 mU/min
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mU/min quarter‐hourly (Group IV)
Trial: 22401642
Drug: Rotigotine 3
RxNorm normalized name: ROTIGOTINE 3MG/24HRS PATCH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rotigotine 3 mg/24 hours via transdermal patch
Trial: 22401642
Drug: Rotigotine 8
RxNorm normalized name: ROTIGOTINE 8MG/24HRS PATCH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rotigotine 8 mg/24 hours via transdermal patch
Trial: 22401642
Drug: Single large
RxNorm normalized name: Bos taurus large intestine preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single large patch vs. 2 smaller patches
Trial: 22401642
Drug: Patch application
RxNorm normalized name: Patch
DrugBank: Lavender oil (DB14566)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patch application sites (hip, shoulder, abdomen, flank, thigh, upper arm)
Trial: 11930708
Drug: Maxillary expansion
RxNorm normalized name: Artemisia capillaris leaf extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maxillary expansion and protraction therapy
Trial: 2874085
Drug: Cefazolin (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefazolin (3 doses of 0.5 g)
Trial: 2874085
Drug: Mezlocillin (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mezlocillin (3 doses of 1 g)
Trial: 22166848
Drug: Combined intensive
RxNorm normalized name: Uricalm Intensive
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Combined intensive treatment of glycemia and blood pressure
Trial: 19384953
Drug: SLC45A2 1721
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SLC45A2 1721 C>G
Trial: 19384953
Drug: ASIP g.8818
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ASIP g.8818 A>G